AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent...
Cancer Today's Winter 2024-25 issue covers the benefits of stereotactic body radiation therapy, geriatric assessment in cancer care, and...
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and...
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers....
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the...